相关实验视频
Updated: May 1, 2026

08:51
Induction of Adhesion-dependent Signals Using Low-intensity Ultrasound
Published on: May 8, 2012
9.5K
NR1I2作为慢性静脉组织的核心生物点,用超声波治疗治疗
Chuanyingzi Lu1, Jingli Zhang, Yajing Zhang
1Rehabilitation Ultrasonics Department, Beijing Rehabilitation Hospital Affiliated to Capital Medical University, Beijing, China.
Medicine
|May 10, 2024
概括
慢性静脉的超声波治疗可能涉及NR1I2.2基因. 这种基因在治疗后表达不足,这表明它在超声波对这些的治疗效果中发挥了作用.
科学领域:
- 分子生物学分子生物学
- 基因组学就是基因组学.
- 医学科学 医学科学 医学科学
背景情况:
- 慢性静脉是持续的皮肤病变.
- 超声波疗法利用超声波能量来调节疾病治疗的组织功能.
研究的目的:
- 为了确定参与慢性静脉的超声波治疗的关键基因.
- 探索超声波治疗作用背后的分子机制.
主要方法:
- 下载的基因表达数据 (GSE222503) 用于超声波治疗的慢性静脉.
- 进行了权重基因共同表达网络分析,功能丰富和蛋白质-蛋白质相互作用网络分析.
- 利用比较性毒基因组学数据库分析来识别基因关联.
主要成果:
- 鉴定了235个不同表达的基因,富含炎症反应和细胞因子-细胞因子受体相互作用等途径.
- 核心基因 (PF4,NR1I2,H3C12,KLRB1) 在经过治疗的中表达不足,在未经治疗的中表达过多.
- NR1I2在经过超声波治疗的慢性静脉组织中表达低,在未经治疗的组织中表达高.
结论:
- 基因NR1I2可能在治疗慢性静脉的超声波疗效方面发挥重要作用.
- NR1I2的表达模式表明它是这种疾病的潜在生物标志物或治疗标.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
615
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
615
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
817
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
817
Myocarditis III: Medical Management
343
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
343
Rheumatic Heart Disease I: Introduction
1.0K
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
1.0K
Rheumatic Heart Disease III: Medical Management
544
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
544
Rheumatic Heart Disease IV: Nursing Management
484
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
484

